Magnetoelectric nanoparticles embedded in a hydrogel and delivered by a threaded acupuncture needle activate mast cells under magnetic fields, producing controllable, sustained pain relief without electrodes.
(Nanowerk Spotlight) Of all the cells clustered beneath an acupuncture point, mast cells may matter most. These immune sentinels sit at the intersection of the body’s nervous and immune systems, packed with chemical mediators they can release in seconds when physically disturbed. A needle insertion tugs on their membranes, opening ion channels and triggering a cascade of signaling molecules that act on nearby nerve endings to quiet pain.
Anatomical mapping has confirmed that acupoints concentrate not just nerve fibers and blood vessels but unusually dense populations of these reactive immune cells.
The biology, then, is increasingly clear. The problem is control. How forcefully and consistently a needle stimulates those mast cells depends on the practitioner’s hand, and no two hands work alike. Electroacupuncture sought to standardize the stimulus by adding electrical pulses, but it requires external power, acts broadly across tissue, and can activate cells beyond the intended target.
Magnetoelectric composite nanomaterials offered a different path forward. Built from a magnetic core and a piezoelectric shell, these particles convert externally applied magnetic fields into coupled mechanical and electrical signals at the nanoscale, with no wires or implanted electronics.
A study published in Advanced Functional Materials (“Chinese Acupuncture Guided by External Magnetic Field for Localized Analgesia”) applies this principle to acupuncture, introducing a hydrogel system that delivers targeted nanoparticles to acupoint tissue and remotely activates mast cells to achieve controlled, sustained local pain relief.
Composition and analgesic mechanism of the magnetoelectric hydrogel acupuncture system. (A) Schematic illustration of the synthesis of mast cell–targeted magneto-responsive piezoelectric nanoparticles (FBTFA). (B) Composition of the magneto-responsive piezoelectric hydrogel (FBTFA@HAMA/HADA). (C) Schematic representation of the magnetoelectric hydrogel acupuncture system, illustrating how external magnetic field stimulation induces localized analgesic effects in arthritic rats through immune–neural interactions at the acupoint. (Image: Reproduced with permission from Wiley-VCH Verlag) (click on image to enlarge)
The nanoparticle at the system’s center has a layered architecture. An Fe₃O₄ (iron oxide) core responds to magnetic fields by moving or deforming. A surrounding BaTiO₃ (barium titanate) shell generates electric charge whenever it experiences mechanical stress. When a magnetic field acts on the core, the resulting motion stresses the shell, producing a localized electric field. Antibodies against FcεRIA, a receptor abundant on mast cell surfaces, direct the particles specifically to their cellular target.
Getting these particles beneath the skin required rethinking the needle. Conventional acupuncture needles have smooth shafts that cannot carry a payload. The team designed a spiral-grooved needle whose helical channels hold a hydrogel made from two forms of modified hyaluronic acid: one providing structural strength, the other enhancing tissue adhesion through dopamine-based chemistry.
After loading the nanoparticle-containing hydrogel into the grooves and crosslinking it with ultraviolet light, a clinician inserts the needle and withdraws it by reverse rotation, depositing the hydrogel at the target depth. Histological staining in rats confirmed the material stayed in place after needle removal.
Cell culture work using RBL-2H3 cells, a standard laboratory model of mast cells, confirmed the system’s biological activity. Cells maintained viability above 80 % at nanoparticle concentrations up to 1000 µg/mL. Antibody-functionalized particles bound to over 50 % of cells within 30 minutes and reached 78.1 % after 6 hours, far outperforming unmodified particles.
A rotating magnetic field then drove the critical functional response. Intracellular calcium levels rose sharply in the nanoparticle-treated group, a necessary precursor to degranulation, the process by which mast cells expel their stored mediators. The degranulation rate reached 50.65 % in the magnetically stimulated group, well above controls. Histamine, serotonin, and extracellular ATP, three molecules with established roles in pain modulation at nerve endings, all increased correspondingly.
Gene expression analysis identified 381 upregulated genes, concentrated in calcium signaling and immune activation pathways, providing molecular confirmation of the cellular responses observed at the bench.
Rats with adjuvant-induced arthritis, a standard model of chronic inflammatory pain, provided the in vivo test. After depositing the nanoparticle-loaded hydrogel at the ST-36 acupoint on the left hind limb, the animals walked freely through a chamber fitted with permanent magnets, receiving dynamic magnetic field exposure of 0 to 6 mT during 10-minute daily sessions over five days.
Mechanical pain thresholds rose significantly in the magnetic stimulation group beginning on day five, outperforming both conventional acupuncture and a control group receiving nanoparticles that lacked the piezoelectric shell. Without the magnetic field, the complete nanoparticles produced no pain relief, confirming the field’s essential activating role.
At the cellular level, 67.5 % of mast cells at the acupoint had degranulated in the magnetically stimulated group, compared with roughly 48 to 49 % for conventional acupuncture and the non-piezoelectric control. Expression of TRPV1, an ion channel involved in transmitting pain signals on sensory nerve endings, decreased. Serum concentrations of the inflammation-driving molecules TNF-α and IL-6 fell to 27.3 % and 15.1 % of pain model levels, respectively.
Farther along the pain pathway, dorsal root ganglia neurons showed increased expression of adenosine A1 receptors alongside reduced levels of c-Fos, a marker of neuronal activation. Cerebrospinal fluid levels of β-endorphin, the body’s own opioid, also rose.
These changes point to a coherent mechanism. Degranulating mast cells release ATP, which extracellular enzymes convert to adenosine. Adenosine activates inhibitory receptors on sensory neurons, dampening their excitability and reducing peripheral pain input. That peripheral quieting may in turn recruit central opioid systems, producing a layered analgesic effect from the acupoint through the spinal cord to the brain.
The study’s authors acknowledge limitations, including incomplete mapping of in vivo magnetic field distribution and the need for longer-term validation and clinical translation studies. What the work does establish is that a single minimally invasive needle insertion, followed by passive magnetic exposure requiring no batteries or electrodes, can drive reproducible mast cell activation and measurable pain relief in an animal model. For a therapeutic tradition built on the variability of the human hand, that represents a meaningful step toward precision.
For authors and communications departmentsclick to open
Lay summary
Prefilled posts
ORCID information
Wenguo Cui (Shanghai Jiao Tong University School of Medicine)
, 0000-0002-6938-9582 corresponding author
Nanowerk Newsletter
Get our Nanotechnology Spotlight updates to your inbox!
Thank you!
You have successfully joined our subscriber list.
Become a Spotlight guest author! Join our large and growing group of guest contributors. Have you just published a scientific paper or have other exciting developments to share with the nanotechnology community? Here is how to publish on nanowerk.com.
